When to test women for human papillomavirus
- 12 January 2006
- Vol. 332 (7533) , 61-13
- https://doi.org/10.1136/bmj.332.7533.61
Abstract
Footnotes Competing interests MS and PEC wrote this article as employees of the US National Cancer Institute and are free from commercial conflicts of interest, but the opinions expressed do not necessarily reflect US government policy. Research pp 79, 83Keywords
This publication has 12 references indexed in Scilit:
- Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studiesBMJ, 2006
- Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after studyBMJ, 2006
- Screen-and-Treat Approaches for Cervical Cancer Prevention in Low-Resource SettingsJAMA, 2005
- Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic AbnormalitiesJNCI Journal of the National Cancer Institute, 2005
- HPV Testing in Cervical Cytology PracticeActa Cytologica, 2005
- Management of women who test positive for high-risk types of human papillomavirus: the HART studyThe Lancet, 2003
- Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA–positive atypical squamous cells of undetermined significance: A two-year prospective studyAmerican Journal of Obstetrics and Gynecology, 2003
- Adding a Test for Human Papillomavirus DNA to Cervical-Cancer ScreeningNew England Journal of Medicine, 2003
- Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University StudentsAmerican Journal of Epidemiology, 2003
- Statistical Issues in Human Papillomavirus Testing and ScreeningClinics In Laboratory Medicine, 2000